연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1307. BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.
Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, Park SY, Jung KC, Koo do H, Youn YK.
World J Surg. 2012 Feb;36(2):310-7. doi: 10.1007/s00268-011-1383-1.
Link
1306. Surgical completeness of bilateral axillo-breast approach robotic thyroidectomy: comparison with conventional open thyroidectomy after propensity score matching.
Lee KE, Koo do H, Im HJ, Park SK, Choi JY, Paeng JC, Chung JK, Oh SK, Youn YK.
Surgery. 2011 Dec;150(6):1266-74. doi: 10.1016/j.surg.2011.09.015.
Link
1305. Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma.
Kim JW, Lee HJ, Yi HG, Kim BS, Bang SM, Kim JS, Kim I, Yoon SS, Lee JS, Kim CS, Park S, Kim BK.
Am J Hematol. 2012 May;87(5):479-83.
Link
1304. Sclerodermatous chronic graft-versus-host disease induced by host T-cell-mediated autoimmunity.
Lee YJ, Min HS, Kang EH, Park HJ, Jeon YK, Kim JH, Wu HG, Lee EB, Park CG, Yoon SS, Park SH, Jung KC.
Immunol Cell Biol. 2012 Mar;90(3):358-67.
Link
1303. Definitive radiotherapy for treatment of primary vaginal cancer: effectiveness and prognostic factors.
Jang WI, Wu HG, Ha SW, Kim HJ, Kang SB, Song YS, Park NH, Kim JW.
Int J Gynecol Cancer. 2012 Mar;22(3):521-7.
Link
1302. Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients.
Lee JH, Wu HG, Kim HJ, Kim DW, Lee SH, Kim TM, Kim YW, Heo DS.
Cancer Res Treat. 2012 Dec;44(4):242-50. doi: 10.4143/crt.2012.44.4.242. Epub 2012 Dec 31.
Link
1301. A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Oh DY, Lee KW, Lee KH, Sohn CH, Park YS, Zang DY, Ryoo HM, Song HS, Kim JS, Kang HJ, Kim BS, Bang YJ.
Invest New Drugs. 2012 Jun;30(3):1164-74.
Link
1300. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
Oh DY, Crawford B, Kim SB, Chung HC, McDonald J, Lee SY, Ko SK, Ro J.
Asia Pac J Clin Oncol. 2012 Sep;8(3):282-91.
Link
1299. Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.
Oh DY, Kim TW, Park YS, Shin SJ, Shin SH, Song EK, Lee HJ, Lee KW, Bang YJ.
Cancer. 2012 Dec 15;118(24):6162-70
Link
1298. Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.
Kim JW, Cha Y, Kim SJ, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ.
Support Care Cancer. 2012 Feb;20(2):395-403.
Link